← Eichor
Study identifier: NCT06681623 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Single-Center Study to Characterize the Safety and Efficacy of Ublituximab in Older Adults With Relapsing Forms of Multiple Sclerosis (RMS)

Condition: Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis  ·  Sponsor: Neurology Center of New England P.C.

PhaseN/A
Planned participants20
Who can joinAll sexes, 55 Years to 80 Years
Healthy volunteersNo

About this study

The purpose of this study is to evaluate the safety of ublituximab use in the older MS adult population, as measured by incidence of infection rate

This description comes directly from the study's public registry record.

Talk to the study team

Salvatore Napoli, MD  ·  781-551-5812  ·  ksciore@myneurodr.com

Rachel ODonnell, BS  ·  781-551-5812  ·  ResearchNCNE@myneurodr.com

Always discuss trial participation with your own doctor first.

Locations (1)

Neurology Center of New England P.C.Foxborough, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06681623